½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹CLPTM1L¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹CLPTM1L¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW14939
    • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·


ÖÐÎÄÃû³Æ£º
Íÿ¹CLPTM1L¶à¿Ë¡¿¹Ìå


Ó¢ÎÄÃû³Æ£ºAnti-CLPTM1L rabbit polyclonal antibody

±ð      Ãû£ºCRR9

Ïà¹ØÀà±ð£ºÒ»¿¹

´¢      ´æ£ºÀä¶³£¨-20¡æ£©

ËÞ      Ö÷£ºRabbit

¿¹      Ô­£ºCLPTM1L

·´Ó¦ÖÖÊô£ºHuman

±ê ¼Ç ÎUnconjugate

¿Ë¡ÀàÐÍ£ºrabbit polyclonal

¼¼Êõ¹æ¸ñ

Background:

Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein), also known as cisplatin resistance-related protein 9 (CRR9p), is a protein that in humans is encoded by the CLPTM1L gene. CRR9p is associated with cisplatin-induced apoptosis. CLPTM1L, which lies within a cancer susceptibility locus on chromosome 5 (5p15.33), has been found to be commonly over-expressed in lung tumors and to confer resistance to apoptosis caused by genotoxic agents in association with up-regulation of the anti-apoptotic protein, Bcl-xL.

Applications:

ELISA, IHC

Name of antibody:

CLPTM1L

Immunogen:

Synthetic peptide of human CLPTM1L

Full name:

CLPTM1-like

Synonyms£º

CRR9

SwissProt:

Q96KA5

ELISA Recommended dilution:

1000-5000

IHC positive control:

Human thyroid cancer and Human esophagus cancer

IHC Recommend dilution:

50-200



¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿